Blockchain Registration Transaction Record

Men Avoid Cancer Genetic Tests Despite Higher Risk, Study Finds

Study shows men make up only 5% of genetic cancer tests despite higher death rates and positive results. Research highlights a critical gender gap in preventive healthcare.

This news matters because it exposes a dangerous gap in preventive healthcare that directly impacts public health outcomes. Men's reluctance to undergo genetic testing for cancer risks, despite their higher mortality rates and greater likelihood of positive results, means many are missing opportunities for early intervention that could save lives. This disparity not only affects individual health but also strains healthcare systems by allowing preventable cancers to progress to more advanced, costly stages. As companies develop new therapies, increasing screening rates could enhance treatment efficacy and reduce overall cancer burden, making this a critical issue for patients, families, and policymakers to address.